HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rotavirus vaccines: an overview.

Abstract
Rotavirus infection is the most common cause of severe diarrhea disease in infants and young children worldwide and continues to have a major global impact on childhood morbidity and mortality. Vaccination is the only control measure likely to have a significant impact on the incidence of severe dehydrating rotavirus disease. In 1999, a highly efficacious rotavirus vaccine licensed in the United States, RotaShield, was withdrawn from the market after 14 months because of its association with intussusception. Two new live, oral, attenuated rotavirus vaccines were licensed in 2006: the pentavalent bovine-human reassortant vaccine (RotaTeq) and the monovalent human rotavirus vaccine (Rotarix). Both vaccines have demonstrated very good safety and efficacy profiles in large clinical trials in western industrialized countries and in Latin America. Careful surveillance has not revealed any increased risk of intussusception in the vaccinated groups with either vaccine. The new rotavirus vaccines are now introduced for routine use in a number of industrialized and developing countries. These new safe and effective rotavirus vaccines offer the best hope of reducing the toll of acute rotavirus gastroenteritis in both developed and developing countries.
AuthorsPenelope H Dennehy
JournalClinical microbiology reviews (Clin Microbiol Rev) Vol. 21 Issue 1 Pg. 198-208 (Jan 2008) ISSN: 1098-6618 [Electronic] United States
PMID18202442 (Publication Type: Journal Article, Review)
Chemical References
  • RIX4414 vaccine
  • RotaTeq
  • Rotavirus Vaccines
  • Vaccines, Attenuated
Topics
  • Administration, Oral
  • Animals
  • Cattle
  • Child, Preschool
  • Clinical Trials as Topic
  • Europe
  • Humans
  • Infant
  • Intussusception (chemically induced)
  • Latin America
  • Rotavirus (classification, genetics, immunology)
  • Rotavirus Infections (prevention & control)
  • Rotavirus Vaccines (administration & dosage, genetics, immunology)
  • Treatment Outcome
  • United States
  • Vaccination
  • Vaccines, Attenuated (administration & dosage, genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: